Tissue Regenix beats the pandemic and returns to double digit growth
Wound specialist Tissue Regenix has reported a return to double digit growth in 2021 after a year of robust trading, despite the challenges of the Covid-19 pandemic and foreign exchange headwinds. ..
Full story on yorkshirepost.co.uk